0001341235-15-000002.txt : 20150205 0001341235-15-000002.hdr.sgml : 20150205 20150205151525 ACCESSION NUMBER: 0001341235-15-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150205 DATE AS OF CHANGE: 20150205 EFFECTIVENESS DATE: 20150205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aldeyra Therapeutics, Inc. CENTRAL INDEX KEY: 0001341235 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-233587 FILM NUMBER: 15579910 BUSINESS ADDRESS: STREET 1: 131 HARTWELL AVENUE STREET 2: SUITE 320 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-761-4904 MAIL ADDRESS: STREET 1: 131 HARTWELL AVENUE STREET 2: SUITE 320 CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: Aldexa Therapeutics, Inc. DATE OF NAME CHANGE: 20130102 FORMER COMPANY: FORMER CONFORMED NAME: Neuron Systems Inc DATE OF NAME CHANGE: 20051012 D 1 primary_doc.xml X0707 D LIVE 0001341235 Aldeyra Therapeutics, Inc. 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA MASSACHUSETTS 02421 781-761-4904 DELAWARE Aldexa Therapeutics, Inc. Neuron Systems Inc Corporation true Todd C. Brady 131 Hartwell Avenue Suite 320 Lexington MA MASSACHUSETTS 02421 Executive Officer Director Stephen Tulipano 131 Hartwell Avenue Suite 320 Lexington MA MASSACHUSETTS 02421 Executive Officer Scott Young 131 Hartwell Avenue Suite 320 Lexington MA MASSACHUSETTS 02421 Executive Officer C.Boyd Clarke 131 Hartwell Avenue Suite 320 Lexington MA MASSACHUSETTS 02421 Director Martin J. Joyce 131 Hartwell Avenue Suite 320 Lexington MA MASSACHUSETTS 02421 Director Gary Phillips 131 Hartwell Avenue Suite 320 Lexington MA MASSACHUSETTS 02421 Director Ben Bronstein 131 Hartwell Avenue Suite 320 Lexington MA MASSACHUSETTS 02421 Director Neal Walker 131 Hartwell Avenue Suite 320 Lexington MA MASSACHUSETTS 02421 Director Jesse I. Treu 131 Hartwell Avenue Suite 320 Lexington MA MASSACHUSETTS 02421 Director Biotechnology Decline to Disclose 06b false 2015-01-21 false true true false 0 4009513 1999997 2009516 Total Offering Amount includes the stock sold and the purchase price and exercise price of the warrants; Total Amount Sold includes the shares of stock and purchase price of warrants; Total Remaining to be Sold includes the exercise price of the warrants. false 1 0 0 0 false Aldeyra Therapeutics, Inc. Todd C. Brady Todd C. Brady President and Chief Executive Officer 2015-02-05